Literature DB >> 18749449

Obstetrics and gynecology-important advances in clinical medicine: exchange transfusion in pregnant women with sickle cell disease.

H W Foster.   

Abstract

The Scientific Board of the California Medical Association presents the following inventory of items of progress in obstetrics and gynecology. Each item, in the judgment of a panel of knowledgeable physicians, has recently become reasonably firmly established, both as to scientific fact and important clinical significance. The items are presented in simple epitome and an authoritative reference, both to the item itself and to the subject as a whole, is generally given for those who may be unfamiliar with a particular item. The purpose is to assist busy practitioners, students, research workers or scholars to stay abreast of these items of progress in obstetrics and gynecology that have recently achieved a substantial degree of authoritative acceptance, whether in their own field of special interest or another.The items of progress listed below were selected by the Advisory Panel to the Section on Obstetrics and Gynecology of the California Medical Association and the summaries were prepared under its direction.

Entities:  

Year:  1983        PMID: 18749449      PMCID: PMC1021559     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  3 in total

1.  Transfusion therapy in pregnant patients with sickle-cell disease: a National Institutes of Health consensus development conference.

Authors:  J C Morrison; H Foster
Journal:  Ann Intern Med       Date:  1979-07       Impact factor: 25.391

2.  Automated erythrocytopheresis for sickle cell anemia during pregnancy.

Authors:  T C Key; E O Horger; E M Walker; E N Mitchum
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

3.  Prophylactic transfusions in pregnant patients with sickle hemoglobinopathies: benefit versus risk.

Authors:  J C Morrison; J M Schneider; W D Whybrew; E T Bucovaz; D M Menzel
Journal:  Obstet Gynecol       Date:  1980-09       Impact factor: 7.661

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.